We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Platelet Rich Plasma Study in Lower Extremity Bypass Surgery (PRP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00517452
Recruitment Status : Completed
First Posted : August 17, 2007
Last Update Posted : January 5, 2011
Sponsor:
Collaborator:
Information provided by:

Study Description
Brief Summary:
The use of platelet rich plasma will decrease wound infection postop.

Condition or disease Phase
Atherosclerosis Phase 2 Phase 3

Study Design

Study Type : Observational
Actual Enrollment : 81 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Phase 2-3 Observational Wound Care Study Comparing Application of Platelet Rich Plasma With Standard of Care Wound Closure in Vascular Patients Requiring a Groin Incision.
Study Start Date : May 2007
Study Completion Date : December 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort
Platelet Rich Plasma
Group received platelet rich plasma and observed over a period of 30 days or until wound closure
Standard Wound Care
Group was treated as per standard care


Outcome Measures

Primary Outcome Measures :
  1. Wound healing [ Time Frame: 4- 6 weeks post op ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   35 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Vascular surgical patients scheduled for elective lower extremity bypass surgery,aortoiliac revascularizations and endovascular AAA repair requiring a groin incision
Criteria

Inclusion Criteria:

  • Vascular surgical patients scheduled for elective lower extremity bypass surgery,aortoiliac revascularizations and endovascular AAA repair requiring a groin incision Exclusion Criteria:Patients requiring emergent procedures, unable to give informed consent
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00517452


Sponsors and Collaborators
Lawson Health Research Institute
Zimmer Biomet
Investigators
Principal Investigator: Kirk D Lawlor London Health Sciences Centre, University of Western Ontario
More Information

Responsible Party: Dr. K. Lawlor, Lawson Health Research Institute
ClinicalTrials.gov Identifier: NCT00517452     History of Changes
Other Study ID Numbers: R-07-098
First Posted: August 17, 2007    Key Record Dates
Last Update Posted: January 5, 2011
Last Verified: January 2011

Additional relevant MeSH terms:
Atherosclerosis
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases